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Abstract
Background: This article estimates non-health gross domestic pro-
duct (GDP) losses associated with Disability-Adjusted Life Years (DALY) 
lost among 15-59 year olds (most productive age bracket) in Kenya 
in 2015. 
Methods: This study employs the lost output or human capital ap-
proach (HCA) to convert the DALYs lost from all causes into their 
monetary equivalents. The magnitude economic haemorrhage from 
each disease was obtained by multiplying the per capita non-health 
GDP in International Dollars by the total number of DALYs lost in a 
specific age group (15-29 years, 30-49 years, 50-59 years). Per capita 
non-health GDP equals per capita GDP minus total health expenditure 
in 2015. Data on DALYs and per capita total health expenditure were 
obtained from the World Health Organization and per capita GDP 
data was from IMF databases. 
Results: Kenya lost 9,405,184 DALYs among 15-59 years olds in 2015. 
That DALY loss caused a haemorrhage in GDP of Int$ 29,788,392,419. 
Approximately 48.6% of the GDP haemorrhage resulted from com-
municable diseases and nutritional conditions, 37.4% from non-com-
municable diseases, and 14.0% from injuries. 
Conclusion: There is need to augment domestic and external inves-
tments into national health systems and other systems that meet basic 
needs (education, food, water, sanitation, shelter) to reduce disease 
burden. 
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Background
Kenya’s population was estimated at 46,034,000 
people in 2015 [1]. In the same year the country lost 
a total of 21,854,898 Disability-Adjusted-Life-Years 
(DALYs) from all causes. Out of that total DALY loss, 
59% were from communicable, maternal, perinatal 
and nutritional conditions; 30% from non-commu-
nicable diseases (NCDs); and 11% from intentional 
and unintentional injuries. About 54% and 46% 
the total DALYs lost occurred in male and female 
gender respectively.
The total DALYs losses were distributed une-
venly across various age groups: 33.2% among 
0-4 year-old; 13.6% among 5-14 year-old; 18.5% 
among 15-29 year-old; 18.8% among 30-49 year-
old; 5.7% among 50-59 year-old; 5.1% among 
60-69 year-old; and 5.1% among those aged 70 
years and above [1]. Thus, 43% of the depletion in 
health or human capital was sustained by the most 
economically and socially productive age bracket 
of 15-59 years. The current study focuses on this 
age bracket.
The large loss in DALYs has been attributed to 
weaknesses in national and local health systems 
responsible for providing quality health services [2, 
3]; systems that assure access to other basic needs 
(food, water, sanitation, education, clothing, shelter) 
or social determinants of health [4, 5]; and national 
health research system that produces knowledge 
and facilitates its use in development of discoveries 
and innovations aimed at addressing health and so-
cioeconomic needs [6, 7].
Various studies have attempted to estimate the 
productivity losses attributable to premature mor-
tality from one or a group of disasters, diseases 
and health conditions in the WHO African Region 
(AFR). A study conducted in 2004 used regression 
modelling to estimate the impact of disaster-related 
mortality on gross domestic product (GDP) in AFR 
[8]. Kirigia et al [9] estimated the effects of maternal 
mortality on GDP in AFR using econometric produc-
tion function modelling. Kirigia et al [10] used cost-
of-illness (COI) method to estimate the economic 
burden of diabetes mellitus in AFR. Kirigia et al [11] 
used COI approach to estimate the economic bur-
den of cholera in AFR. Okorosobo et al [12] used a 
combination of methods to estimate the economic 
burden of malaria in five AFR countries. Orem et al 
[13] used production function approach to estimate 
the impact of malaria morbidity on GDP in Uganda. 
Kirigia et al [14] used COI approach to estimate the 
indirect cost of maternal deaths in AFR. Kirigia et al 
[15] used COI approach to estimate the cost of child 
mortality in the AFR.
Kirigia et al [16] estimated the indirect cost as-
sociated with deaths from the Ebola Virus disease 
in West Africa. Kirigia and Muthuri [17] estimated 
productivity losses associated with tuberculosis 
deaths in AFR. Kirigia et al [18] estimated the indi-
rect cost of maternal deaths in the AFR. Kirigia et al 
[19] estimated indirect cost of non-communicable 
diseases deaths in the AFR. Those studies have two 
main limitations. First, they all estimated the pro-
ductivity losses attributable to premature deaths 
but omitted the economic impact of non-fatal di-
sability resulting from various diseases or health 
conditions. Second, none of those studies estima-
ted the productivity losses of premature mortality 
from all causes. Third, except for Kirigia et al [20] 
study on the indirect cost of DALYs lost among the 
elderly in Kenya, no other study in Kenya has at-
tempted estimate the GDP losses emanating from 
DALYs lost. 
The objective of this study was to estimate non-
health gross domestic product (GDP) losses associa-
ted with DALYs lost among 15-59 year-old in Kenya 
in 2015. 
Methods
Study area and population
The study reported in this paper focusses on all 
DALYs lost among 15-59 year olds in Kenya, i.e. 
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the most economically productive age bracket. 
The study encompasses all communicable disea-
ses, maternal conditions, neonatal conditions and 
nutritional deficiencies; a wide range of NCDs, 
including 24 malignant neoplasms, 11 mental 
and substance-use disorders, 7 neurological con-
ditions, 7 sense-organ diseases, 6 cardiovascular 
diseases, respiratory diseases, 9 digestive disea-
ses, 6 genitourinary diseases, 5 musculoskeletal 
diseases, 6 congenital anomalies, oral conditions 
and sudden infant death; and intentional and 
unintentional injuries reported in the 2015 World 
Health Organization (WHO) global health (DALY) 
estimates [1].
Study design
The lost output or human capital 
approach
This study employs the lost output or human capital 
approach (HCA) to convert the DALYs lost in Kenya 
in 2015 from all causes into their monetary equiva-
lents. The approach was first used in 1699 [21], and 
its theoretical underpinnings honed in subsequent 
studies [22, 23, 24, 24]. The availability of data on 
DALYs, total health expenditure per capita and GDP 
per capita for Kenya influenced our choice of HCA. 
The per capita GDP of Kenya is equals total expen-
diture (i.e. consumption expenditure, investment, 
government expenditure and net exports) divided 
by total population. Our hypothesis is that DALY 
losses from any disease haemorrhages incomes of 
households and firms (and hence consumption ex-
penditure), savings (and hence resources available 
for investment), taxes and service fees (and hence 
revenues available for government spending), and 
numbers of export producers (and hence quantity 
of exports). 
The Murray [25], Struijk et al [26] and WHO [27] 
global heath estimates technical papers details DALY 
methods and data sources. 
Kenya’s non-health GDP haemorrhage (NHGDPHA) 
associated with DALYs lost from kth disease (or 
health condition) is the sum of the NHGDPHA due to 
DALYs lost from kth disease among people aged 15-
29 years (NHGDPA15-29), 30-49 years (NHGDPA30-49), 
and 50-59 years (NHGDPA50-59)
The NHGDPHA linked with kth disease among 
persons of a specific age group equals non-health 
GDP per capita times total DALYs lost from kth di-
sease. Kenya’s discounted NHGDPHA attributable 
to kth disease was calculated using the equations 
(1) to (4): 
NHGDPHAk=
NHGDPA15-29+ NHGDPA30-49+ NHGDPA50-59  
1
NHGDPA15-29=[NHGDPPCInt$] x [DALY15-29]  2
NHGDPA30-49=[NHGDPPCInt$] x [DALY30-49]  3
NHGDPA50-59=[NHGDPPCInt$] x [DALY50-59]  4
Where: NHGDPPCInt$: is per capita non-health 
GDP in purchasing power parity (PPP), obtained 
by subtracting per capita total health expenditure 
(PCTHE) from per capita GDP (GDPPCInt$) [14-20]; 
DALY15-29 is the number of DALYs lost from kth di-
sease among those aged 15-29 years in Kenya in 
2015; DALY30-49 is the number of DALYs lost from 
kth disease among those aged 30-49 years in Kenya 
in 2015; and DALY50-59 is the number of DALYs lost 
from kth disease among those aged 50-59 years in 
Kenya in 2015. Discount factor was not introduced 
in equation (2) to (4) because DALY estimates con-
tained in the WHO Global Health Observatory are 
already discounted at a rate of 3% [27].
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Data Sources
The aforementioned four equations were estima-
ted using secondary data from per capita GDP data 
from the International Monetary Fund (IMF) World 
Economic Outlook database [28], per capita total 
health expenditure from the WHO Global Health 
Expenditure Database [29], and DALYs data from 
the WHO Global Health Observatory [1].
Data Analysis
The Excel Software developed by Microsoft (New 
York) was used to estimate equations (1) to (4).
Results
Kenya sustained a loss of 9,405,184 DALYs among 
15-59 years olds in 2015. That DALY loss caused 
a haemorrhage in GDP of Int$ 29,788,392,419. 
About 43% of the economic loss was sustained by 
the 15-29 year-old; 43.7% by the 30-49 year-old; 
and 13.3% by the 50-59 year-old.
GDP haemorrhage from communicable disea-
ses and nutritional conditions indirect costs
About Int$ 14,482,888,888 (48.6%) of total GDP 
haemorrhage was caused by communicable disea-
ses and nutritional conditions (CDs). This loss was 
due to four categories of causes. First, 3,403,288 
DALYs were lost from infectious and parasitic disea-
ses, which was equivalent to Int$10,779,561,469 
(74%) (Figure 1). Eighty-five percent of this loss 
was from HIV/AIDS, diarrhoea diseases, parasitic 
and vector diseases, tuberculosis, and meningitis.
Figure 1:  GDP haemorrhage from infectious and parasitic diseases 15-59 year olds in Kenya in 2015 (Int$).
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Figure 2:  GDP haemorrhage from respiratory infections, maternal and neonatal conditions, and nutri-
tional deficiencies among 15-59 year olds in Kenya in 2015 (Int$).
Figure 3:  GDP haemorrhage from non-communicable diseases among 15-59 year olds in Kenya in 2015 
(Int$).
Second, 297,097 DALYs were lost from respi-
ratory infections, which was equivalent to Int$ 
940,973,619 (Figure 2). 
Ninety-three percent of the loss emanated from 
lower respiratory infections. Third, maternal and 
neonatal conditions led to a loss of 560,389 DALYs, 
equivalent to Int$ 1,774,881,139. Fourth, nutritional 
deficiencies resulted in 311,778 DALYs lost, which 
was equal to Int$ 987,472,662. Eighty-four percent 
of the latter loss was from iron-deficiency anaemia 
and 11% from protein-energy malnutrition.
GDP haemorrhage from non-communicable 
diseases (NCDs) 
Approximately Int$ 11,132,722,393 (37.4%) of total 
GDP haemorrhage was caused by non-communica-
ble diseases (NCDs) (Figure 3). That productivity loss 
was attributed to 16 broad causes. 
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First, malignant neoplasms (Cancers) haemorr-
haged 648,090 DALYs, which was equal to Int$ 
2,040,790,854. Five cancers accounted for 42.3% 
of the productivity losses, including cervix uteri can-
cer, breast cancer, oesophagus cancer, lymphomas 
and multiple myeloma, and mouth and oropharynx 
cancers (Figure 4).
Second, other neoplasms, diabetes mellitus and 
endocrine/blood/immune disorders led to a loss 
of 248,457 DALYs causing a haemorrhage of Int$ 
786,920,661, i.e. 7.1% of the total GDP loss in Ken-
ya (Table 1).
Third, mental and substance use disorders resul-
ted in 696,354 DALY loss, which caused a haemorr-
hage in GDP of Int$ 2,205,514,227 (19.8%). About 
79.4% of the GDP loss resulted from depressive 
disorders, bipolar disorder, schizophrenia, alcohol 
use disorders, and anxiety disorders (Table 2).
Figure 4:  GDP haemorrhage from malignant neoplasms (Cancers) among 15-59 year-old in Kenya in 
2015 (Int$).
Table 1.  GDP haemorrhage from other neoplasms 
(Cancers), diabetes mellitus, and endocri-
ne/blood/immune disorders among 15-59 
year olds in Kenya in 2015 (Int$).
Diseases/conditions DALY
GDP Losses 
(Int$)
Percent
Other neoplasms 9,260 29,328,148 0.3
Diabetes mellitus 117,193 371,177,384 3.3
Endocrine, blood, immune 
disorders (a+b+c+d)
122,004 386,415,128 3.5
a. Thalassaemia 1,425 4,513,713 1.2
b.  Sickle cell disorders and 
trait
90,249 285,840,938 74.0
c.  Other 
haemoglobinopathies 
and haemolytic 
anaemias
21,054 66,683,416 17.3
d.  Other endocrine, blood 
and immune disorders
9,275 29,377,062 7.6
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Table 3.  GDP haemorrhage from neurological con-
ditions among 15-59 year-old in Kenya in 
2015 (Int$)
Neurological 
conditions
DALY GDP Loss (Int$) Percent
1.  Alzheimer 
disease and other 
dementias
2,092 6,625,654 0.9
2. Parkinson disease 591 1,870,735 0.3
3. Epilepsy 104,273 330,256,875 44.2
4. Multiple sclerosis 1,296 4,104,649 0.5
5. Migraine 102,935 326,019,488 43.6
6.  Non-migraine 
headache
16,939 53,649,829 7.2
7.  Other 
neurological 
conditions
7,936 25,136,471 3.4
Total 236,062 747,663,702 100
Table 2.  GDP haemorrhage from DALYs lost from mental and substance use disorders among 15-59 year-
olds in Kenya in 2015 (Int$).
Mental and substance use disorders  DALY  GDP Loss (Int$) Percent
1 Depressive disorders (a+b) 311,308 985,983,108 44.7
a. Major depressive disorder 270,427 856,506,048 86.9
b.Dysthymia 40,880 129,477,060 13.1
2. Bipolar disorder 45,923 145,447,571 6.6
3. Schizophrenia 49,157 155,692,769 7.1
4.  Alcohol use disorders 50,878 161,141,684 7.3
5. Drug use disorders (a+b+c+d+e) 13,582 43,018,488 2.0
a.Opioid use disorders 10,486 33,210,103 77.2
b. Cocaine use disorders 316 1,001,333 2.3
c. Amphetamine use disorders  423 1,340,938 3.1
d. Cannabis use disorders 1,921 6,084,236 14.1
e. Other drug use disorders 436 1,381,878 3.2
6. Anxiety disorders 95,528 302,558,471 13.7
7. Eating disorders 3,464 10,971,219 0.5
8.  Autism and Asperger syndrome 37,989 120,319,915 5.5
9. Childhood behavioural disorders (a+b) 17,037 53,958,942 2.4
a.  Attention deficit/hyperactivity syndrome 2,061 6,526,788 12.1
b.Conduct disorder 14,976 47,432,154 87.9
10.  Idiopathic intellectual disability 29,502 93,440,122 4.2
11.  Other mental and behavioural disorders 41,987 132,981,938 6.0
Total 696,354 2,205,514,227 100 
Table 4.  GDP haemorrhage from DALYs lost from 
sense organ diseases among 15-59 year-
olds in Kenya in 2015 (Int$).
Sense organ 
diseases
DALY
GDP Loss 
(Int$)
Percent
 1. Glaucoma 865 2,738,480 0.8
 2. Cataracts 6,207 19,659,908 5.9
 3.  Uncorrected 
refractive errors 
15,500 49,090,982 14.7
 4.  Macular 
degeneration 
710 2,248,227 0.7
 5.  Other vision 
loss 
14,270 45,197,672 13.6
 6.  Other hearing 
loss 
52,217 165,383,404 49.6
 7.  Other sense 
organ disorders 
15,492 49,066,231 14.7
 Total 105,261 333,384,904 100 
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Table 6.  GDP haemorrhage from digestive diseases among 15-59 year-old in Kenya in 2015 (Int$).
Digestive diseases DALY GDP Loss (Int$) Percent
1. Peptic ulcer disease 33,847 107,201,715 9.3
2. Cirrhosis of the liver (a+b+c+d) 137,232 434,644,576 37.9
a. Cirrhosis due to hepatitis B 37,547 118,919,196 27.4
b. Cirrhosis due to hepatitis C 12,761 40,417,916 9.3
c. Cirrhosis due to alcohol use 64,321 203,719,038 46.9
d. Other liver cirrhosis 22,603 71,588,426 16.5
3. Appendicitis 11,519  36,484,855 3.2
4.  Gastritis and duodenitis 28,267 89,528,397 7.8
5.  Paralytic ileus and intestinal obstruction 85,434 270,590,268 23.6
6.  Inflammatory bowel disease 19,029 60,270,279 5.3
7.  Gallbladder and biliary diseases 11,660 36,929,535 3.2
8. Pancreatitis 9,578 30,334,718 2.6
9.  Other digestive diseases 25,826 81,795,656 7.1
 Total 362,392  1,147,779,998  
Table 5.  GDP haemorrhage from cardiovascular di-
seases among 15-59 year-old in Kenya in 
2015 (Int$).
Cardiovascular 
diseases
DALY
GDP Loss 
(Int$)
Percent
1.  Rheumatic heart 
disease 18,600  58,910,580 4.3
2.  Hypertensive heart 
disease
44,390 140,594,328 10.2
3.  Ischaemic heart 
disease 
111,944 354,551,267 25.7
4. Stroke (a+b) 161,604 511,838,612 37.1
a. Ischaemic stroke 23,478 74,360,714 14.5
b.  Haemorrhagic 
stroke 
138,126 437,477,898 85.5
5.  Cardiomyopathy, 
myocarditis, 
endocarditis 
23,794 75,360,220 5.5
6.  Other circulatory 
diseases 
75,252 238,340,264 17.3
Total 435,584 1,379,595,271 100 
Fourth, 236,062 DALYs were lost from neurologi-
cal conditions translating to Int$ 747,663,702 GDP 
loss, i.e. 6.7% of losses related to NCDs (Table 3). 
Epilepsy and migraine accounted for 87.8% of neu-
rological conditions.
Fifth, 105,261 DALYs were lost from neurologi-
cal conditions translating to Int$ 333,384,904 GDP 
loss, i.e. 3% of losses related to NCDs (Table 4). 
Other hearing loss, uncorrected refractive errors, 
and other vision loss accounted for 77.9% of GDP 
losses attributed to sense organ diseases.
Sixth, 435,584 DALYs were lost from cardiovascu-
lar diseases haemorrhaging Int$1,379,595,271, i.e. 
12.4% of the total losses related to NCDs (Table 5). 
Hypertensive heart disease, ischaemic heart disease 
and stroke were responsible for 73% of cardiovas-
cular diseases related GDP losses.
Seventh, 145,343 DALYs were lost from respiratory 
diseases haemorrhaging GDP by Int$ 460,335,371, 
i.e. 4.1% of total NCD productivity losses. About 
32%, 59% and 9% of those losses resulted from 
chronic obstructive pulmonary disease, asthma and 
other respiratory diseases respectively.
Eighth, 362,392 DALY loses stemmed from di-
gestive diseases, which in turn accounted for Int$ 
1,147,779,998, i.e. 10.3% of NCD-related economic 
losses (Table 6). About 70.8% of the digestive di-
sease GDP loss was caused by peptic ulcer disease, 
cirrhosis of the liver, and paralytic ileus and intestinal 
obstruction.
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Table 8.  GDP haemorrhage from musculoskeletal diseases, congenital anomalies, and oral conditions 
among 15-59 year-olds in Kenya in 2015 (Int$)
Diseases DALY GDP Loss (Int$) Percent
1. Musculoskeletal diseases 311,308 985,983,108 44.7
a.  Rheumatoid arthritis 270,427 856,506,048 86.9
b. Osteoarthritis 40,880 129,477,060 13.1
c. Gout 45,923 145,447,571 6.6
d.  Back and neck pain 49,157 155,692,769 7.1
e.  Other musculoskeletal disorders 50,878 161,141,684 7.3
2. Congenital anomalies (a+b+c+d+e+f) 92,250 292,177,791 2.6
a.  Neural tube defects 6,072 19,230,532 6.6
b.  Cleft lip and cleft palate 196 620,116 0.2
c.  Down syndrome 6,778 21,466,108 7.3
d.  Congenital heart anomalies 35,107 111,192,151.3 38.1
e.  Other chromosomal anomalies 4,226 13,384,109 4.6
f.  Other congenital anomalies 39,872 126,284,775 43.2
3. Oral conditions (a+b+c+d) 45,597 144,417,218 1.3
a. Dental caries 3,928 12,439,523 8.6
b.  Periodontal disease 20,833 65,982,699 45.7
c. Edentulism 5,450 17,262,220 12.0
d.  Other oral disorders 15,387 48,732,777 33.7
Table 7.  GDP haemorrhage from genitourinary diseases among 15-59 year-old in Kenya in 2015 (Int$).
Genitourinary diseases DALY  GDP Losses (Int$) Percent
1. Kidney diseases (a+b+c) 62,611 198,303,186 39.2
a. Acute glomerulonephritis 329 1,042,783 0.5
b. Chronic kidney disease due to diabetes 18,593 58,887,298 29.7
c. Other chronic kidney disease 43,689 138,373,104 69.8
 2. Benign prostatic hyperplasia 1,739 5,506,804 1.1
 3. Urolithiasis (urinary tract stones) 693 2,194,317 0.4
 4. Other urinary diseases 18,921 59,927,015 11.8
 5. Infertility 18,332 58,060,186 11.5
 6.  Gynaecological diseases 57,614 182,478,397 36.0
 Total 159,909 506,469,904 100.0
Ninth, 159,909 DALYs were caused by geni-
tourinary diseases, which haemorrhaged Int$ 
506,469,904 (4.5% of NCD-related GDP losses) (Ta-
ble 7). Gynaecological diseases and kidney diseases 
accounted for 75.2% of the GDP losses related to 
genitourinary diseases.
Tenth, 88,172 DALYs were lost from skin diseases, 
which contributed to Int$ 279,261,398 haemorrha-
ge in GDP, i.e. 2.5% in NCD-related productivity 
losses. 
Eleventh, 255,242 DALYs were lost from muscu-
loskeletal diseases, congenital anomalies, and oral 
conditions, haemorrhaging Int$ 808,411,093 in 
GDP, i.e. 7.3% in NCD-related productivity losses. 
Approximately, 54.2% of musculoskeletal diseases 
losses emanated from back and neck pain; 38.1% 
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congenital anomalies GDP losses were from conge-
nital heart anomalies; and 45.7% of oral condition 
losses were from periodontal diseases (Table 8).
GDP haemorrhage from injuries
Twelfth, 1,317,485 DALYs lost were from injuries, 
which haemorrhaged Int$ 4,172,781,137 of GDP, 
i.e. 14% of the grand total productivity losses from 
all causes (Figure 5). About 73.8% of the losses 
were from unintentional injuries; and the remai-
ning 26.2% from intentional injuries. Sixty-four 
percent of the unintentional injuries GDP losses 
were from road injury and exposure to mechanical 
forces. Ninety-six percent of the intentional injuries 
GDP losses resulted from self-harm and interper-
sonal violence. 
Discussion
The 9,405,184 DALYs lost among 15-59 years olds 
are estimated to have haemorrhaged equivalent to 
21% of Kenya’s GDP in 2015. In other words, if 
Kenya could avert all the DALYs lost in 2015, it could 
increase its GDP by 21%. Kenya could potentially 
avert majority of the GDP losses from communica-
ble and non-communicable diseases and injuries by 
implementing pertinent policies and strategies agre-
ed upon at the United Nations General Assembly, 
World Health Assembly, African Union and WHO 
Regional Committee for Africa. 
Global and regional policies and strategies 
for combatting communicable diseases
HIV/AIDS
In May 2016, the Sixty-ninth World Health Assembly 
(WHA) endorsed the Global Health Sector Strategy 
for HIV (2016-2021) [30] that envisions zero new 
HIV infections, zero HIV-related deaths and zero 
HIV-related discrimination in a world where people 
living with HIV are able to live long and healthy lives 
[30, 31]. Its goal is to end the AIDS epidemic as a 
public health threat by 2030, within the context 
of ensuring healthy lives and promoting well-being 
for all at all ages [31]. The strategy has five stra-
tegic directions: strategic information for focussed 
action and accountability, essential interventions for 
impact, delivering for quality and equity, financing 
for sustainability and financial risk protection, and 
innovation to bridge knowledge and technological 
gaps for acceleration [31]. The 62nd WHO Regio-
Figure 5:  GDP haemorrhage from injuries among 15-59 year-old in Kenya in 2015 (Int$).
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nal Committee for Africa resolution AFR/RC62/
R2 adapted the global HIV strategy to the African 
region context to facilitate implementation of the 
global strategy [32]. 
Diarrhoeal diseases
The Thirty-first WHA resolution WHA31.44 of 
1978 urged Member States to implement effective 
interventions for prevention and case management 
of diarrhoeal diseases in the primary health care 
context [33]. The 1987 Fortieth WHA resolution 
WHA40.34 underscores that prevention of dia-
rrhoeal diseases entails improving nutrition, pro-
moting breast-feeding, access to and use of safe 
water, personal hygiene (including hand washing 
with soap), sanitation, and immunization against 
measles [34]. It also adds that an effective dia-
rrhoeal diseases control programme must include 
careful planning, adequate health manpower trai-
ning and information, effective communication as 
well as education on health, sanitation, nutrition 
promotion, adequate production, distribution and 
social marketing of oral rehydration preparations, 
and appropriate supervision, monitoring and eva-
luation [34]. The 2011 Sixty-fourth WHA resolution 
WHA64.15 called upon Member States to mobili-
ze sufficient technical and financial resources for 
coordinated and multi-sectoral measures for pre-
paration, prevention and control of cholera [35]. 
The 2017 cholera outbreaks in Kenya’s Nairobi 
capital city clearly indicates that there is need for 
implementing sectoral and inter-sectoral interven-
tions (health education, personal hygiene, potable 
water, improved sanitation, environmental condi-
tions and cultural practices) to prevent recurrence 
of diarrhoeal diseases [36]. 
Parasitic and vector diseases
The Seventieth World Health Assembly in 2017 
through its resolution WHA70.16, adopted the 
Global Vector Control Response 2017-2030, which 
envisions a world free of human suffering from 
vector-borne diseases [37]. According to the WHA 
resolution and strategy, Kenya’s national vector 
control strategy and operational plan(s) should, 
among others, feature needs assessment and re-
source mobilization plan; training of relevant staff 
from national and County ministries of health in pu-
blic health entomology; establishment of functional 
national institutional network(s) to support educa-
tion and training in public health entomology; and 
development of a national agenda for basic and 
applied research on entomology and vector con-
trol. In order significantly reduce the burden and 
threat of vector-borne diseases, Kenya’s strategic 
vector control plan will need to be supported by 
four pillars: inter- and intra-sectoral action and co-
llaboration; engaging and mobilizing communities; 
enhancing vector surveillance and monitoring and 
evaluation of interventions; and scaling up and in-
tegrating tools and approaches [38].
Tuberculosis
The Sixty-Seventh WHA, in 2014, through resolu-
tion WHA67.1 adopted the global strategy and tar-
gets for tuberculosis (TB) prevention, care and con-
trol after 2015 [39]. The strategy envisions a world 
without TB. It targets ending the global TB epidemic 
by 2035 through a reduction in TB deaths by 95% 
and in TB incidence by 90%, and elimination of 
associated catastrophic costs for TB-affected hou-
seholds. The strategy has three pillars: integrated, 
patient-centred care and prevention (early diagnosis 
of TB, treatment of all people with TB, management 
of HIV/TB co-morbidities, preventive treatment of 
persons at high risk, and vaccination against TB); 
bold policies and supportive systems (adequate re-
sources for TB care and prevention, engagement of 
stakeholders, social protection, and universal health 
coverage policy and regulatory frameworks); and in-
tensified research and innovation (development and 
uptake of new tools, optimization of implementa-
tion) [40]. 
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Meningococcal meningitis
The WHO strategy for the control of epidemic me-
ningitis is based on three key pillars: surveillance (to 
detect the first cases, identify the pathogen as well 
as the serogroup of the meningococcus); treatment 
and care (providing prompt, appropriate, accessible 
and affordable treatment with antibiotics and care); 
and vaccination (large-scale vaccination of popula-
tion groups that are at risk) [41]. 
Global and regional policies and strategies 
for battling non-communicable diseases
Following the adoption of the UN General Assem-
bly (UNGA) decisions [42, 43, 44], WHA resolutions 
[45, 46, 47, 48], and WHO Regional Committee for 
Africa resolutions [49,50,51] related to NCDs, WHO 
specified 10 indicators which the Director-General 
will use to report [52], by the end of 2017, to the 
UNGA on the progress achieved in the implemen-
tation of the time-bound commitments included in 
the 2014 Outcome Document [53]. By end of 2015, 
Kenya had fully achieved the following: formulated 
national NCDs targets and indicators; developed 
national integrated NCD policy/strategy/action plan; 
developed public awareness on diet and/or physical 
activity; articulated guidelines for the management 
of major NCDs; and legislated tobacco advertising 
ban. The country had partially achieved the indica-
tors on: risk factor surveys, health warnings tobacco 
demand-reduction measure, and harmful use of al-
cohol reduction measures, such as availability of re-
gulations, advertising and promotion bans, and pri-
cing policies. The following indicators had not been 
achieved: NCD mortality data surveillance; taxation 
and smoke-free policies tobacco demand-reduction 
measures; unhealthy diet reduction measures (salt/
sodium policies, saturated fatty acids and trans-fats 
policies, marketing to children restrictions, and mar-
keting of breast-milk substitutes restrictions); and 
drug therapy/counselling for high risk persons [52]. 
The 2030 Agenda for Sustainable Development 
aims to reduce premature deaths from NCDs by 
one-third by 2030 (SDG target 3.4), strengthen im-
plementation of the WHO Framework Convention 
on Tobacco Control (FCTC) (3.a), strengthen the 
prevention and treatment to reduce the harmful 
use of alcohol (3.5), support the research and de-
velopment on medicines for NCDs that primarily 
affect developing countries (3.b), and achieve uni-
versal health coverage (3.8) [54]. This historic deci-
sion to include NCDs within the scope of SDGs is 
grounded in the commitments made at two high-
level meetings of the UNGA in 2011 and 2014 to 
track the exponential increase in prevalence of 
NCDs and its impact on development, make pre-
vention the cornerstone of the global response, 
and strengthen national health systems capacities 
tackle NCD epidemic [44, 53].
Kenya national policies and strategies 
for combatting communicable and non-
communicable diseases
Kenya’s national health policy goal is to attain 
the highest possible health standard in a manner 
responsive to the population needs through pro-
vision of equitable, affordable and quality health 
and related services to all Kenyans [55]. Its policy 
objectives are to eliminate communicable diseases; 
halt and reverse rising burden of NCD’s; reduce the 
burden of violence and injuries; provide essential 
health services; minimize exposure to health risk 
factors; and strengthen collaboration with private 
and health-related sectors. Kenya national health 
sector strategic plan (NHSSP) expounds on the 
strategies for realizing those policy objectives [56]. 
It explains how investments would be increased 
and efficiently utilized to strengthen health system 
building blocks (organization of services, health 
workforce, health infrastructure, health products 
and technologies, health information and research, 
health finance, and leadership and governance) at 
community, primary, county and national levels to 
provide unfettered access to an Essential Package 
of Health Services to all Kenyans in need. However, 
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Kenya’s current total health expenditure per capi-
ta of US$68 [29] is far much lower than the USD 
US$ 271 total cost per person needed to achieve 
health SDG 3 [57].
Global and regional policies and strategies 
for preventing injuries
Road traffic injuries and Interpersonal violen-
ce alone account for 55.6% of violence-related 
productivity losses. Due to great concern about 
health losses attributable to road traffic accidents 
the UNGA adopted eight resolutions on impro-
ving global road safety between 2003 and 2014 
[58-65]. The 2010 resolution proclaims the period 
2011–2020 as the Decade of Action for Road Sa-
fety, with a goal of stabilizing and then reducing 
road traffic fatalities [60]. It called upon member 
states to implement road safety activities, parti-
cularly in the areas of road safety management, 
road infrastructure, vehicle safety, and road user 
behaviour, among others.
The UNGA has also adopted conventions and 
resolutions for curbing other forms of injuries. The 
Convention on the Elimination of All Forms of Dis-
crimination Against Women (CEDAW) asserts the 
rights of women and elimination of all forms of dis-
crimination [66]. The UNGA A/RES/48/104 asserted 
women’s right to life and called upon governments 
to budget adequate resources for implementing 
action plans to eliminate all forms of violence aga-
inst women [67]. By resolution A/RES/54/134, the 
UNGA designated 25 November as the International 
Day for the Elimination of Violence against Women 
[68].
This political momentum culminated in UNGA 
adoption of its resolution A/RES/70/1 of 25 Sept-
ember 2015 entitled “Transforming our world: the 
2030 Agenda for Sustainable Development” [54]. 
The Goal 3 on ensuring healthy lives and promoting 
well-being for all at all ages has a target 3.6, which 
aspires to halve the number of global deaths and 
injuries from road traffic accidents by 2020 [54]. 
Thus, there is political commitment at the UNGA 
Heads of State level to curb injuries. What about 
at the WHA? 
The UNGA in 2004 designated WHO the coor-
dinator on road safety issues [63]. WHO accepted 
the responsibility through resolution WHA57.10 
[69]. Subsequently, in 2007, the WHA adopted re-
solution WHA60.22 calling upon Member States 
to strengthen emergency care systems to improve 
provision of trauma and emergency care [70]. The 
WHA resolution WHA69.7 of 2016 urged Member 
States to implement the Brasília Declaration on Road 
Safety [71]; commit to implement the Decade of 
Action for Road Safety 2011−2020 and the Glo-
bal Plan for the Decade of Action for Road Safety 
2011−2020 [72]; develop and implement a national 
strategy and action plan; adopt and enforce laws on 
the key risk factors (speeding, drinking alcohol and 
driving; non-use of motorcycle helmets, seat-belts 
and child restraints; distracted or impaired driving), 
improve the quality of road safety data; and im-
prove prevention and emergency medicine training 
programmes [73].
The Sixty-seventh WHA, in 2014, adopted re-
solution WHA67.15 that urges Member States to 
develop comprehensive and effective multi-sectoral 
response to interpersonal violence against women, 
girls and children [74]. The Sixty-Ninth WHA, in 
2016, adopted resolution WHA69.5 urging Member 
States to implement the WHO global plan of action 
to strengthen the role of the health system within 
a national multi-sectoral response to address inter-
personal violence against women, girls and children 
[75]. Thus, there is expressed commitment among 
global ministers of health to tackle injuries in coun-
tries. Is there commitment at Africa continent level 
prevent injuries?
At the Continental level, the African Union has 
a Road Safety Charter [76] and an African Road 
Safety Action Plan [77]. In order for African cou-
ntries to fully implement the action plan, the First 
Ordinary Session of the African Union Specialized 
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Technical Committee, recommended that Member 
States create and/or strengthen their Lead Road 
Safety Agencies, involve private sector and civil 
society organizations, build a critical mass of ski-
lled road safety experts, modernize management 
of national database on road safety, strengthen 
human and financial resources of emergency ser-
vices of hospitals, develop national monitoring fra-
meworks, enhance sensitization on Road Safety, 
sustainably finance national road safety program-
me, celebrate the African Road Safety Day on 18th 
November, and appoint high-level political Road 
Safety Champions [78]. 
In order to curb domestic violence, the African 
Union adopted the Protocol to enshrining the Rights 
of Women in Africa. The protocol calls upon Sta-
te Parties to enact and enforce laws to prohibit all 
forms of violence against women including unwan-
ted or forced sex whether the violence takes place 
in private or public [79]. Thus, political commitment 
also exists within the African Union to curb all forms 
of injuries.
Does commitment exist among ministers of 
health in Africa? The WHO Regional Committee 
for Africa has over the years adopted a number of 
resolutions aimed at injury prevention and control. 
Resolution AFR/RC53/R3 urges Member States to 
adopt and implement national policies and pro-
grammes on injury and violence prevention and 
control [80]. Resolution AFR/RC53/R4 called upon 
Member States to accelerate the implementation 
of interventions aimed at eliminating all forms of 
violence and harmful traditional practices [81]. Re-
solution AFR/RC58/R1 called upon Member States 
to consider in women’s health policies, the preven-
tion of early and forced marriages, gender-based 
violence and all forms of discrimination against 
women, and adopt and enforce relevant legislation 
[82]. Resolution AFR/RC63/R4 called upon mem-
ber states to intensify action aimed at eliminating 
violence against women, gender discrimination, 
sexual coercion, early marriage and harmful tradi-
tional practices such as female genital mutilation 
[83]. There seems to be expressed commitment 
among ministers of health in the AFR.
Kenya national policies and strategies for 
preventing injuries
Since this paper is on indirect cost of DALYs lost in 
Kenya, is there commitment to tackle injuries? At 
the national level, Article 26 of Kenya’s Constitu-
tion asserts every person’s right to life; and Article 
29 assures the right to security of the person, in-
cluding the right not to be subjected to any form 
of violence from public or private sources [84]. The 
country has a National Transport Safety Authority 
(NTSA) whose functions are to implement policies 
relating to road transport and safety; plan, manage 
and regulate the road transport system; and ensu-
re the provision of safe, reliable and efficient road 
transport services [85, 86]. Kenya has a compre-
hensive road safety action plan [87]. The country 
also has a Prohibition of Female Genital Mutilation 
(FGM) Act No. 32 of 2011 prohibiting the practice 
of FGM and safeguarding against violation of a 
person’s mental or physical integrity through the 
practice of FGM [88]. In addition, Kenya has an 
Act of Parliament aimed at providing protection 
and relief of victims of domestic violence [89]. The 
existing legal framework and plans of action for 
preventing intentional and unintentional injuries 
have not been fully implemented due to inade-
quacy of inter-sectoral resources allocated for the 
purpose [90]. 
Limitation of this study
This study has a number of limitations. First, the fo-
cus of the current study was on productivity losses 
attributable to DALYs lost in Kenya in 2015. Thus, 
the study omitted direct health systems costs, e.g., 
health workforce time, medicines, diagnosis, health 
facility buildings and equipment.
Second, the DALY index has been criticized for 
age weighting (giving more weight to DALYs lost 
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among people in economically productive age brac-
ket), discounting, and using the highest average life 
expectancy in the world instead of each country’s 
average [91,92]. Furthermore, given Kenya’s weak 
vital registration system for births and deaths, esti-
mations of years of life lost are based on a combi-
nation of second-best approaches.
Third, the study uses GDP per capita to moneta-
rily value DALYs lost. The GDP has been criticized 
for omitting contributions of full-time home-makers 
(e.g. housewives), for not reflecting inequalities in 
income distribution, and for valuing leisure activities 
at zero [93-96].
Fourth, if the HCA strictly is applied, the DALYs 
lost by the unemployed and full-time homemakers 
would be valued at zero [23, 97, 98]. In order to 
alleviate the impact of this limitation, the current 
study valued all the DALYs lost using the same 
per capita GDP, without adjusting for employment 
rates.
Conclusion
Annually Kenya suffers considerable GDP haemo-
rrhage due to non-fatal disability and prematu-
re mortality among the 15-59 year olds, i.e. the 
most productive age bracket in Kenya’s population. 
Majority of the health and economic haemorrha-
ge from all causes can be averted using available 
proven promotive, preventive, curative and reha-
bilitative interventions. On paper, there exists po-
litical commitment at global, continental, regio-
nal and national levels to stem the tide of DALY 
haemorrhage. However, the political commitment 
does not seem to have translated into allocation 
of adequate budget for implementing existing po-
licy and legal frameworks and action plan(s) to 
tackle the root causes DALY losses [3]. Thus, the 
need for evidence-based advocacy among national 
and county governments, private sector (industry) 
and external development partners to increase and 
use all available health development resources more 
efficiently to strengthen performance of health sys-
tems [2, 99, 100, 101, 102], national health research 
and innovation system [6, 7], and other systems that 
tackle social determinants of health (e.g. education, 
food, water, sanitation and shelter) [4] cannot be 
overemphasized.
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